|
1
|
Ringe KI, Panzica M and von Falck C:
Thermoablation of bone tumors. Rofo. 188:539–550. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Goldsby R, Burke C, Nagarajan R, Zhou T,
Chen Z, Marina N, Friedman D, Neglia J, Chuba P and Bhatia S:
Second solid malignancies among children, adolescents, and young
adults diagnosed with malignant bone tumors after 1976: Follow-up
of a Children's Oncology Group cohort. Cancer. 113:2597–2604. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Calais J, Fendler WP, Herrmann K, Eiber M
and Ceci F: Reply: Comparison of 68Ga-PSMA-11 and
18F-fluciclovine PET/CT in a case series of 10 patients
with prostate cancer recurrence: prospective trial is on its way. J
Nucl Med. 59:8612018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Paskeviciute B, Bölling T, Brinkmann M,
Rudykina G, Ernst I, Stegger L, Schober O, Willich N, Weckesser M
and Könemann S: Impact of 18F-FDG-PET/CT on staging and
irradiation of patients with locally advanced rectal cancer.
Strahlenther Onkol. 185:260–265. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bundschuh RA, Dinges J, Neumann L,
Seyfried M, Zsótér N, Papp L, Rosenberg R, Becker K, Astner ST,
Henninger M, et al: Textural parameters of tumor heterogeneity in
¹8F-FDG PET/CT for therapy response assessment and
prognosis in patients with locally advanced rectal cancer. J Nucl
Med. 55:891–897. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fendler WP, Eiber M, Beheshti M, Bomanji
J, Ceci F, Cho S, Giesel F, Haberkorn U, Hope TA, Kopka K, et al:
68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure
guideline for prostate cancer imaging: version 1.0. Eur J Nucl Med
Mol Imaging. 44:1014–1024. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jo HJ, Kim SJ, Kim IJ and Kim S:
Predictive value of volumetric parameters measured by F-18 FDG
PET/CT for lymph node status in patients with surgically resected
rectal cancer. Ann Nucl Med. 28:196–202. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Thorek DL, Ulmert D, Diop NF, Lupu ME,
Doran MG, Huang R, Abou DS, Larson SM and Grimm J: Non-invasive
mapping of deep-tissue lymph nodes in live animals using a
multimodal PET/MRI nanoparticle. Nat Commun. 5:30972014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hameed M and Dorfman H: Primary malignant
bone tumors - recent developments. Semin Diagn Pathol. 28:86–101.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Azcona C, Burghard E, Ruza E, Gimeno J and
Sierrasesúmaga L: Reduced bone mineralization in adolescent
survivors of malignant bone tumors: Comparison of quantitative
ultrasound and dual-energy X-ray absorptiometry. J Pediatr Hematol
Oncol. 25:297–302. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Knoeller SM, Uhl M, Gahr N, Adler CP and
Herget GW: Differential diagnosis of primary malignant bone tumors
in the spine and sacrum. The radiological and clinical spectrum:
Minireview. Neoplasma. 55:16–22. 2008.PubMed/NCBI
|
|
12
|
Westhovens R and Dequeker J:
Musculoskeletal manifestations of benign and malignant tumors of
bone. Curr Opin Rheumatol. 15:70–75. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Maury CPJ: Amyloid and the origin of life:
Self-replicating catalytic amyloids as prebiotic informational and
protometabolic entities. Cell Mol Life Sci. 75:1499–1507. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ulaner GA, Castillo R, Wills J, Gönen M
and Goldman DA: 18F-FDG-PET/CT for systemic staging of
patients with newly diagnosed ER-positive and HER2-positive breast
cancer. Eur J Nucl Med Mol Imaging. 44:1420–1427. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Janssen JC, Meißner S, Woythal N, Prasad
V, Brenner W, Diederichs G, Hamm B and Makowski MR: Comparison of
hybrid 68Ga-PSMA-PET/CT and
99mTc-DPD-SPECT/CT for the detection of bone metastases
in prostate cancer patients: Additional value of morphologic
information from low dose CT. Eur Radiol. 28:610–619. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
London K, Stege C, Cross S, Onikul E, Graf
N, Kaspers G, Dalla-Pozza L and Howman-Giles R: 18F-FDG
PET/CT compared to conventional imaging modalities in pediatric
primary bone tumors. Pediatr Radiol. 42:418–430. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Costelloe CM, Chuang HH, Chasen BA, Pan T,
Fox PS, Bassett RL and Madewell JE: Bone windows for distinguishing
malignant from benign primary bone tumors on FDG PET/CT. J Cancer.
4:524–530. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guimaraes JB, Facchetti L, Rigo L, Garcia
DL, Gama P, Franc BL and Nardo L: The role of PET/CT in the
assessment of primary bone tumors. Curr Radiol Rep. 4:532016.
View Article : Google Scholar
|
|
19
|
Kitajima K, Fukushima K, Yamamoto S, Kato
T, Odawara S, Takaki H, Fujiwara M, Yamakado K, Nakanishi Y,
Kanematsu A, et al: Diagnostic performance of
11C-choline PET/CT and bone scintigraphy in the
detection of bone metastases in patients with prostate cancer.
Nagoya J Med Sci. 79:387–399. 2017.PubMed/NCBI
|
|
20
|
El-Galaly TC, Gormsen LC and Hutchings M:
PET/CT for staging; Past, present, and future. Semin Nucl Med.
48:4–16. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Partovi S, Kohan A, Rubbert C,
Vercher-Conejero JL, Gaeta C, Yuh R, Zipp L, Herrmann KA, Robbin
MR, Lee Z, et al: Clinical oncologic applications of PET/MRI: A new
horizon. Am J Nucl Med Mol Imaging. 4:202–212. 2014.PubMed/NCBI
|
|
22
|
Al-Bulushi NK and Abouzied ME: Comparison
of 18F-FDG PET/CT scan and 99mTc-MDP bone
scintigraphy in detecting bone metastasis in head and neck tumors.
Nucl Med Commun. 37:583–588. 2016. View Article : Google Scholar : PubMed/NCBI
|
